Table 1.
Transcriptional regulator activity associated with breast cancer overall survival
| Regulator | log-rank p | HR | 95% CI | p value |
|---|---|---|---|---|
| BATF | 3.00E-06 | 0.45 | (0.32–0.64) | 5.26E-06 |
| ESR1 | 0.002 | 0.60 | (0.43–0.83) | 0.0023 |
| IRF1 | 0.0034 | 0.62 | (0.44–0.85) | 0.0037 |
| THAP1 | 0.0099 | 1.53 | (1.10–2.12) | 0.0105 |
| KDM1A | 0.0158 | 0.67 | (0.48–0.93) | 0.0165 |
| TBP | 0.0167 | 1.49 | (1.07–2.06) | 0.0173 |
| JUNB | 0.0199 | 0.68 | (0.49–0.94) | 0.0206 |
| ATF3 | 0.021 | 0.69 | (0.50–0.95) | 0.0218 |
| CHD7 | 0.0236 | 1.45 | (1.05–2.01) | 0.0243 |
| STAT2 | 0.032 | 0.70 | (0.51–0.97) | 0.0329 |
| GTF2B | 0.04 | 0.71 | (0.52–0.99) | 0.0409 |
| IKZF1 | 0.0406 | 0.71 | (0.52–0.99) | 0.0416 |
| FOXA1 | 0.0459 | 0.72 | (0.52–1.00) | 0.0469 |
| MAX | 0.046 | 0.72 | (0.52–1.00) | 0.0469 |
| REST | 0.0493 | 1.38 | (1.00–1.91) | 0.0502 |
*HR Hazard ratio, CI confidence interval